US Stock MarketDetailed Quotes

LXEO Lexeo Therapeutics

Watchlist

6.200
+0.080+1.31%

Close Nov 21 16:00 ET

205.01MMarket Cap-2367P/E (TTM)

Lexeo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-60.53%654K

Operating revenue

--0

-60.53%654K

--0

Cost of revenue

Gross profit

Operating expense

55.59%31.54M

68.52%23.55M

20.74%23.29M

12.02%68.51M

-1.47%14.97M

12.55%20.27M

-8.95%13.98M

19.29M

16.96%61.16M

15.2M

Selling and administrative expenses

168.25%8.12M

155.20%6.99M

164.69%7.55M

28.18%15.38M

77.53%6.76M

14.18%3.03M

-11.10%2.74M

--2.85M

67.31%12M

--3.81M

-General and administrative expense

168.25%8.12M

155.20%6.99M

164.69%7.55M

28.18%15.38M

77.53%6.76M

14.18%3.03M

-11.10%2.74M

--2.85M

67.31%12M

--3.81M

Research and development costs

35.82%23.42M

47.38%16.56M

-4.23%15.74M

8.07%53.13M

-27.90%8.21M

12.26%17.25M

-8.40%11.24M

--16.44M

8.96%49.16M

--11.39M

Operating profit

-55.59%-31.54M

-68.52%-23.55M

-20.74%-23.29M

-13.23%-68.51M

1.47%-14.97M

-15.96%-20.27M

8.73%-13.98M

-19.29M

-19.50%-60.51M

-15.2M

Net non-operating interest income expense

371.79%2.06M

330.73%2.31M

153.38%1.61M

115.72%2.66M

69.13%1.05M

2.11%436K

219.64%537K

637K

8,126.67%1.23M

622K

Non-operating interest income

328.69%2.09M

297.97%2.35M

140.32%1.65M

116.38%2.87M

63.02%1.1M

7.02%488K

233.33%590K

--687K

8,733.33%1.33M

--676K

Non-operating interest expense

-32.69%35K

-33.96%35K

-26.00%37K

125.27%205K

-7.41%50K

79.31%52K

488.89%53K

--50K

--91K

--54K

Other net income (expense)

98.89%-3K

66.67%-1K

-25.00%-5K

-27,050.00%-543K

-265K

-271K

-3K

-4K

-2K

Gain on sale of security

----

---530K

---258K

---272K

----

Other non- operating income (expenses)

-400.00%-3K

66.67%-1K

-25.00%-5K

-550.00%-13K

---7K

--1K

---3K

---4K

---2K

----

Income before tax

-46.65%-29.49M

-58.01%-21.24M

-16.21%-21.68M

-12.01%-66.39M

2.68%-14.19M

-17.90%-20.11M

11.24%-13.44M

-18.66M

-17.10%-59.28M

-14.58M

Income tax

Net income

-46.65%-29.49M

-58.01%-21.24M

-16.21%-21.68M

-12.01%-66.39M

2.68%-14.19M

-17.90%-20.11M

11.24%-13.44M

-18.66M

-17.10%-59.28M

-14.58M

Net income continuous Operations

-46.65%-29.49M

-58.01%-21.24M

-16.21%-21.68M

-12.01%-66.39M

2.68%-14.19M

-17.90%-20.11M

11.24%-13.44M

---18.66M

-17.10%-59.28M

---14.58M

Minority interest income

Net income attributable to the parent company

-46.65%-29.49M

-58.01%-21.24M

-16.21%-21.68M

-12.01%-66.39M

2.68%-14.19M

-17.90%-20.11M

11.24%-13.44M

-18.66M

-17.10%-59.28M

-14.58M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-46.65%-29.49M

-58.01%-21.24M

-16.21%-21.68M

-12.01%-66.39M

2.68%-14.19M

-17.90%-20.11M

11.24%-13.44M

-18.66M

-17.10%-59.28M

-14.58M

Basic earnings per share

-11.40%-0.89

-19.85%-0.64

-3.88%-0.77

-426.51%-12.4

8.07%-0.5324

-17.90%-0.7989

11.24%-0.534

-0.7413

-17.10%-2.3551

-0.5792

Diluted earnings per share

-11.40%-0.89

-19.85%-0.64

-3.88%-0.77

-426.51%-12.4

8.07%-0.5324

-17.90%-0.7989

11.24%-0.534

-0.7413

-17.10%-2.3551

-0.5792

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	-60.53%654K	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	-60.53%654K	--0
Cost of revenue
Gross profit
Operating expense	55.59%31.54M	68.52%23.55M	20.74%23.29M	12.02%68.51M	-1.47%14.97M	12.55%20.27M	-8.95%13.98M	19.29M	16.96%61.16M	15.2M
Selling and administrative expenses	168.25%8.12M	155.20%6.99M	164.69%7.55M	28.18%15.38M	77.53%6.76M	14.18%3.03M	-11.10%2.74M	--2.85M	67.31%12M	--3.81M
-General and administrative expense	168.25%8.12M	155.20%6.99M	164.69%7.55M	28.18%15.38M	77.53%6.76M	14.18%3.03M	-11.10%2.74M	--2.85M	67.31%12M	--3.81M
Research and development costs	35.82%23.42M	47.38%16.56M	-4.23%15.74M	8.07%53.13M	-27.90%8.21M	12.26%17.25M	-8.40%11.24M	--16.44M	8.96%49.16M	--11.39M
Operating profit	-55.59%-31.54M	-68.52%-23.55M	-20.74%-23.29M	-13.23%-68.51M	1.47%-14.97M	-15.96%-20.27M	8.73%-13.98M	-19.29M	-19.50%-60.51M	-15.2M
Net non-operating interest income expense	371.79%2.06M	330.73%2.31M	153.38%1.61M	115.72%2.66M	69.13%1.05M	2.11%436K	219.64%537K	637K	8,126.67%1.23M	622K
Non-operating interest income	328.69%2.09M	297.97%2.35M	140.32%1.65M	116.38%2.87M	63.02%1.1M	7.02%488K	233.33%590K	--687K	8,733.33%1.33M	--676K
Non-operating interest expense	-32.69%35K	-33.96%35K	-26.00%37K	125.27%205K	-7.41%50K	79.31%52K	488.89%53K	--50K	--91K	--54K
Other net income (expense)	98.89%-3K	66.67%-1K	-25.00%-5K	-27,050.00%-543K	-265K	-271K	-3K	-4K	-2K
Gain on sale of security	----	----	----	---530K	---258K	---272K	----	----	----	----
Other non- operating income (expenses)	-400.00%-3K	66.67%-1K	-25.00%-5K	-550.00%-13K	---7K	--1K	---3K	---4K	---2K	----
Income before tax	-46.65%-29.49M	-58.01%-21.24M	-16.21%-21.68M	-12.01%-66.39M	2.68%-14.19M	-17.90%-20.11M	11.24%-13.44M	-18.66M	-17.10%-59.28M	-14.58M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-46.65%-29.49M	-58.01%-21.24M	-16.21%-21.68M	-12.01%-66.39M	2.68%-14.19M	-17.90%-20.11M	11.24%-13.44M	-18.66M	-17.10%-59.28M	-14.58M
Net income continuous Operations	-46.65%-29.49M	-58.01%-21.24M	-16.21%-21.68M	-12.01%-66.39M	2.68%-14.19M	-17.90%-20.11M	11.24%-13.44M	---18.66M	-17.10%-59.28M	---14.58M
Minority interest income
Net income attributable to the parent company	-46.65%-29.49M	-58.01%-21.24M	-16.21%-21.68M	-12.01%-66.39M	2.68%-14.19M	-17.90%-20.11M	11.24%-13.44M	-18.66M	-17.10%-59.28M	-14.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-46.65%-29.49M	-58.01%-21.24M	-16.21%-21.68M	-12.01%-66.39M	2.68%-14.19M	-17.90%-20.11M	11.24%-13.44M	-18.66M	-17.10%-59.28M	-14.58M
Basic earnings per share	-11.40%-0.89	-19.85%-0.64	-3.88%-0.77	-426.51%-12.4	8.07%-0.5324	-17.90%-0.7989	11.24%-0.534	-0.7413	-17.10%-2.3551	-0.5792
Diluted earnings per share	-11.40%-0.89	-19.85%-0.64	-3.88%-0.77	-426.51%-12.4	8.07%-0.5324	-17.90%-0.7989	11.24%-0.534	-0.7413	-17.10%-2.3551	-0.5792
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data